About MHS Pharmaceuticals Private Limited
Data last updated:
MHS Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Medplus Health Services Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 June 2008.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2008PTC059624. The company has 4 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹7.01 Cr and a paid-up capital of ₹7.01 Cr. It was led by directors Paidiwar Srinivas and Bhaskar Reddy Cherukupalli.
Its last annual general meeting (AGM) was held on 10 July 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹72.2 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net loss of ₹16.4 Lakh (net margin -22.7%) and EBITDA of ₹58.4 Lakh (EBITDA margin 80.9%). Revenue has declined at a compounded annual rate (CAGR) of 71% over three years and 58% over five years.
Court records list 10 cases involving the company, including 6 filed by the company and 4 filed against it; 2 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in September 2015. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is Icon Lifecare Private Limited with revenue of ₹72.54 Lakh. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers.
The last known website on record is medplusindia.com.
Company details
CIN history
MHS Pharmaceuticals has one previous CIN (Corporate Identification Number): U24233AP2008PTC059624. The current CIN is U24233TG2008PTC059624, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2008PTC059624 | Current |
| U24233AP2008PTC059624 | Previous |
Contact details
MHS Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is medplusindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Apps
- Registered AddressH. No: 11 – 6 – 56 Survey No: 257 & 258/1 Opp:Idpl Railway Siding Road (Moosapet), Kukatpally, Hyderabad, Telangana, India – 500037
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of MHS Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of MHS Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of MHS Pharmaceuticals Private Limited
FY 2024 filings availableMHS Pharmaceuticals Private Limited reported revenue of ₹72.2 Lakh (down 27% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 58% over five years, including a 27% fall in the latest year. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹16.4 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 80.9% | ||||
| Net Profit Margin | -22.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of MHS Pharmaceuticals Private Limited, buy the company report.
Board of directors of MHS Pharmaceuticals Private Limited
MHS Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Paidiwar Srinivas Also directs: Dureleg Manufacturing Private Limited, Sai Sridhar Pharma Private Limited, Wynclark Pharmaceuticals Private Limited and 5 more | Director | 04 Apr 2011 | 15 Years 6 Months | As last reported |
| Bhaskar Reddy Cherukupalli Also directs: Wynclark Pharmaceuticals Private Limited, Clearancekart Private Limited, Kalyani Meditimes Private Limited and 5 more | Director | 12 Jun 2008 | 18 Years 4 Months | As last reported |
Peer comparison
MHS Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Icon Lifecare Private Limited | ₹72.54 Lakh (FY 2024) | 21.0% | Hathras, Uttar Pradesh, India | |||
| Studdmed Healthcare Private Limited | ₹72.53 Lakh (FY 2025) | 90.0% | Tarapur, Assam, India | |||
| Ambush Pharmaceuticals Private Limited | ₹72.21 Lakh (FY 2016) | 93.0% | Karnal, Haryana, India | |||
| MHS Pharmaceuticals Private Limitedthis company | ₹72.2 Lakh (FY 2024) | -₹16.4 Lakh | -22.7% | -27.0% | Hyderabad, Telangana, India | |
| Styris Pharma Private Limited | ₹71.98 Lakh (FY 2021) | -32.0% | Telangana, India | |||
| Newmark Biosciences Private Limited | ₹71.96 Lakh (FY 2024) | -13.0% | Bareilly, Uttar Pradesh, India |
To see the full peer comparison of MHS Pharmaceuticals Private Limited, buy the company report.
Auditor
MHS Pharmaceuticals Private Limited is audited by Gphk & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gphk & Associates | FY 2023 | 008053S |
Shareholding
The shareholding of MHS Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of MHS Pharmaceuticals Private Limited, buy the company report.
Deals & funding
MHS Pharmaceuticals Private Limited has 2 deals on record (2 secondary share transfers); the latest was in September 2015.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2009 | Secondary share transfer | Undisclosed | Buyer: Medplus Health Services Limited , an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
MHS Pharmaceuticals Private Limited has 10 court cases on record: 6 filed by MHS Pharmaceuticals, 4 filed against it. 2 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 3 | 2 |
| NCLT | 3 | 0 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Centaur Pharmaceuticals Pvt Ltd | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Centaur Pharmaceuticals Pvt Ltd Asian Patent Law | Pending |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Centaur Pharmaceuticals Pvt Ltd | Disposed |
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| NCLT, Hyderabad | Interim or miscellaneous application | Filed by the company | Disposed |
To see the full case history of MHS Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
MHS Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pegasus Farmaco (India) Private Limited | |||
| Sabari Homwell Corporation |
To see the full MSME payment records of MHS Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
MHS Pharmaceuticals has 4 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of MHS Pharmaceuticals Private Limited, buy the company report.
Recent activity
MHS Pharmaceuticals Private Limited has 7 board changes on record since 2008: 2 appointments and 5 cessations. The latest: Prasad Reddy Battinapatla ceased to be Director on 25 Apr 2024.
News
Frequently asked questions
MHS Pharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
MHS Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 June 2008 and is registered under CIN U24233TG2008PTC059624. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
MHS Pharmaceuticals was incorporated on 12 June 2008. It is registered with the Registrar of Companies, Hyderabad.
MHS Pharmaceuticals had 2 directors:
- Paidiwar Srinivas - Director
- Bhaskar Reddy Cherukupalli - Director
The CIN (Corporate Identification Number) of MHS Pharmaceuticals is U24233TG2008PTC059624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of MHS Pharmaceuticals is at H. No: 11 – 6 – 56 Survey No: 257 & 2581 Opp:Idpl Railway Siding Road Moosapet, Kukatpally, Hyderabad, Telangana, India – 500037.
MHS Pharmaceuticals can be reached through the website medplusindia.com. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of MHS Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 10 July 2024. Year-wise statements from 2015 are in the company report.
No. MHS Pharmaceuticals has 4 GST registrations on record and all of them are cancelled or inactive.
MHS Pharmaceuticals operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
MHS Pharmaceuticals has 2 deals on record (2 secondary share transfers); the latest was in September 2015.
The peers of MHS Pharmaceuticals by revenue are Icon Lifecare Private Limited, Studdmed Healthcare Private Limited, Ambush Pharmaceuticals Private Limited, Styris Pharma Private Limited, Newmark Biosciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
